Apellis Pharmaceuticals
APLS
#2206
Rank
$5.83 B
Marketcap
$52.77
Share price
-0.02%
Change (1 day)
41.78%
Change (1 year)

P/S ratio for Apellis Pharmaceuticals (APLS)

P/S ratio as of January 2023 (TTM): 51.1

According to Apellis Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 51.1363. At the end of 2022 the company had a P/S ratio of 66.4.

P/S ratio history for Apellis Pharmaceuticals from 2017 to 2022

PS ratio at the end of each year

Year P/S ratio Change
202266.4-4.02%
202169.2300.1%
202017.3
2019N/A
2018N/A
2017N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/A-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA